Projects per year
Personal profile
Academic Biography
Current Position
Director of the National Horizons Centre, Darlington, UK (https://www.tees.ac.uk/nhc/)
Member of Teesside University Senior Management Team
As Director of the National Horizons Centre (NHC) at Teesside University I am responsible for leading the NHC's development as a centre of excellence for the biosciences and healthcare sectors. With research, partnerships and training at our core, the NHC brings together industry, the NHS, academia, talent and world-class facilities to create real-world impact. Working closely with our partners we put business at the forefront of innovation and train the workforce of tomorrow to address the technical and digital skills and needs of the sector. As an active researcher. I play a key role supporting the full research and innovation lifecycle, from early diagnosis of diseases to manufacturing medicines with a focus on patient benefit.
Please contact me if you would like further information or to discuss potential collaborations and opportunities – [email protected]
Follow - @vikkirand, @RandLabUK, @TU_NHC, @TeessideUni
Connect on LinkedIn - professorvikkirand
Rand Lab - Cancer Genomics and Global Health
The overall aims of my research is to understand the biology of lymphoma and other cancers in order to identify biomarkers and develop new treatment strategies to reduce treatment-related toxicity in order to improve outcome of relapsed/refractory disease. Using a combination of cutting-edge techniques we are determining the presence, frequency and structure of genetic abnormalities in childhood and adult cancers in the UK, Africa and beyond. We are investigating the clinical importance of these genetic abnormalities by correlating the genetic data with clinical information and investigating the role of these abnormalities in the cancer cell.
My drive is to improve the lives of people in the UK and beyond through skills development and driving innovation. I am open to discussing where I can support local, national and international collaborative research, training and associated bids and opportunities. An example of current collaborative programme:
Northern Health Futures: Digital Health Hub for the North East and North Cumbria (NortHFutures)
The EPSRC Funded Northern Health Futures (NortHFutures) hub is tackling place-based health and social inequalities through the development of community infrastructures to develop a health-tech innovation ecosystem aiming to widen participation and digital training opportunities for diverse stakeholder. Leading the engagement, networking and entrepreneurship WP5 and am part of the leadership team driving digital skills training (WP3). As part of the leadership team, I support the other WP across research, creating a supportive community and hub management(https://northfutures.org/).
Qualifications
2004 PhD Genomics and Bioinformatics, University of Cambridge/Wellcome Trust Sanger Institute
1999 First Class BSc(Hons) Biomedical Sciences, University of Bradford
Previous Positions
Oct 2019-Nov 2021 Director of Research for the National Horizons Centre Darlington, UK (https://www.tees.ac.uk/nhc/) and the Centre of Biodiscovery in the School of Health and Life Sciences, Teesside University, Middlesbrough, UK (https://www.tees.ac.uk/schools/shls/)
Sept 2012-Sept 2019 Bloodwise (formerly Leukaemia and Lymphoma Research) Senior Bennett Fellow and Lymphoma Genomics Group Leader, Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, UK
Sept 2010-August 2012 Lecturer in Cancer Genetics, Northern Institute for Cancer Research, Newcastle University
Sept 2008-August 2010 Lecturer Cancer Genetics in Leukaemia Research Cytogenetics Group (LRCG), Northern Institute for Cancer Research, Newcastle University
Jan 2006-Aug 2008 Postdoctoral Research Fellow, Children's Brain Tumour Research Centre, University of Nottingham
Jan 2004-Dec 2005 Postdoctoral Research Fellow, Department of Neurosurgery, Johns Hopkins University, US
Membership and external positions
Director for the UniAlliance Doctoral Training Alliance (DTA) in Applied Biosciences for Health
British Society of Haematology (BSH)
Children's Cancer & Leukaemia Group (CCLG)
Cambridge Philosophical Society
External Examiner Cancer Biology Specialist Royal College of Radiologists, Lincoln’s Inn Field, London
Children’s Cancer and Leukaemia Group Biological Studies Committee Member
External positions
Associate , Newcastle University
31 Oct 2019 → …
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Biological Invasions and Disease in Argentina
Bojko, J. (PI), Taylor, G. (PI) & Rand, V. (PI)
1/06/20 → …
Project: Research
-
Translation of TP53 status as a prognostic biomarker in aggressive paediatric lymphoma for use in a Clinical Trail
Rand, V. (CoI)
Rosetrees Trust and the Stoneygate Trust
1/05/22 → 30/04/23
Project: Research
-
MinION sequencing project
Rand, V. (CoI)
North East Promenaders Against Cancer (NEPAC)
1/04/22 → 31/03/23
Project: Research
-
Comparative genomics for Agmasoma sp. (Microsporidia) parasitising invasive Carcinus aestuarii and Carcinus maenas in Argentina
Bojko, J., Frizzera, A., Vázquez, N., Taylor, G., Rand, V. & Cremonte, F., 1 Jun 2023, In: Journal of Invertebrate Pathology. 198, 5 p., 107908.Research output: Contribution to journal › Article › peer-review
Open AccessFile99 Downloads (Pure) -
Single-cell DNA sequencing identifies risk-associated clonal complexity and evolutionary trajectories in childhood medulloblastoma development
Danilenko, M., Zaka, M., Keeling, C., Crosier, S., Lyman, S., Finetti, M., Williamson, D., Hussain, R., Coxhead, J., Zhou, P., Hill, R. M., Hicks, D., Rand, V., Joshi, A., Schwalbe, E. C., Bailey, S. & Clifford, S. C., 1 Sept 2022, In: Acta Neuropathologica. 144, 3, p. 565-578 14 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile68 Downloads (Pure) -
Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma
Newman, A., Zaka, M., Zhou, P., Blain, A. E., Erhorn, A., Barnard, A., Crossland, R. E., Wilkinson, S., Enshaei, A., Zordi, J. D., Harding, F., Taj, M., Wood, K. M., Televantou6, D., Turner, S. D., Burke, G. A. A., Harrison, C. J., Bomken, S., Bacon, C. M. & Rand, V., 21 Oct 2021, In: Leukemia. e-pubResearch output: Contribution to journal › Article › peer-review
Open AccessFile211 Downloads (Pure) -
Low BACH2 Expression Predicts Adverse Outcome in Chronic Lymphocytic Leukaemia
Ciardullo, C., Szoltysek, K., Zhou, P., Pietrowska, M., Marczak, L., Willmore, E., Enshaei, A., Walaszczyk, A., Ho, J. Y., Rand, V., Marshall, S., Hall, A., Harrison, C. J., Soundararajan, M. & Eswaran, J., 21 Dec 2021, In: Cancers. 14, 1, 23.Research output: Contribution to journal › Article › peer-review
Open AccessFile108 Downloads (Pure) -
Sequential inverse dysregulation of the RNA helicases DDX3X and DDX3Y facilitates MYC-driven lymphomagenesis
Gong, C., Krupka, J. A., Gao, J., Grigoropoulos, N. F., Giotopoulos, G., Asby, R., Screen, M., Usheva, Z., Cucco, F., Barrans, S., Painter, D., Zaini, N. B. M., Haupl, B., Bornelöv, S., Ruiz De Los Mozos, I., Meng, W., Zhou, P., Blain, A. E., Forde, S. & Matthews, J. & 17 others, , 25 Aug 2021, In: Molecular Cell. 81, 19, p. 4059–4075Research output: Contribution to journal › Article › peer-review
Open AccessFile169 Downloads (Pure)
Press/Media
-
Funding announced for NortHFutures Digital Health Hub
10/06/23
1 item of Media coverage
Press/Media: Press / Media
-
Research could herald new treatments for childhood cancer
15/11/21
1 item of Media coverage
Press/Media: Press / Media
-
NortHFutures: New Digital Health Hub across the North East and North Cumbria
14/06/23
1 item of Media coverage
Press/Media: Press / Media
-
Distinguished Indian visitors tour Teesside University facility
10/03/23
1 item of Media coverage
Press/Media: Press / Media
-
Future vaccine makers to get VR-assisted training centre of excellence
Rand, V., Akram, M. S. & Gaskell, C.
14/03/24
1 item of Media coverage
Press/Media: Press / Media